ArtemiC

MGC Pharma's COVID-19 Treatment Shows No Pathological Impact on Major Organs

MGC Pharmaceuticals' latest animal study on its novel COVID-19 treatment 'ArtemiC', revealed the formula causes "no pathological changes" in major organs.MGC Pharmaceuticals (ASX: ...

Animal Study Confirms Safety of MGC Pharma's 'ArtemiC'

MGC Pharmaceuticals undertook safety and toxicity pre-clinical studies using in vivo testing on mice in Israel and found that ArtemiC delivered "no adverse results in standard toxi...